Abstract
Peripheral neuropathy is a major adverse effect in the use of chemotherapeutic drugs. In nearly 50% of patients, chemotherapy induced peripheral neuropathy (CIPN) has been reported as irreversible. With increasing numbers of patients surviving treatment as well as increasing duration of survival after treatment, reducing the side effects of chemotherapy and improving the quality of life has become a major focus of cancer survivorship. Multiple classes of chemotherapeutic drugs including taxanes, platinum agents and vinka alkaloids list peripheral neuropathy as the main dose-limiting side effect of treatment. We previously found that drugs that interfere with the microtubule function, including taxanes and vinca alkaloids, bind to neuronal calcium sensor 1 (NCS1), leading to aberrant calcium signaling. The altered calcium signaling can be mitigated by application of drugs used to treat bipolar disease (e.g., lithium and valproic acid) prior to initiation of chemotherapy. Because pre-treatment with these drugs prevented CIPN in mice treated with taxanes, we sought clinical evidence by performing a retrospective chart review study of the VA electronic health record to see whether or not there would be evidence to support our scien...Continue Reading
References
Feb 22, 1979·Nature·P B SchiffS B Horwitz
May 5, 1971·Journal of the American Chemical Society·M C WaniA T McPhail
Jan 1, 1984·Pharmacology & Therapeutics·J J Manfredi, S B Horwitz
Apr 1, 1995·Seminars in Oncology·L C DrinkardE E Vokes
Jun 21, 2001·American Journal of Epidemiology·D B Dunson
May 13, 2006·The Journal of Clinical Investigation·Christina SchleckerBarbara E Ehrlich
Nov 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Wolfgang BoehmerleBarbara E Ehrlich
Jun 22, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wolfgang BoehmerleBarbara E Ehrlich
Aug 3, 2011·The Journal of Biological Chemistry·Jennifer H BenbowBarbara E Ehrlich
Aug 5, 2011·Clinical Pharmacology and Therapeutics·D R PachmanC L Loprinzi
Aug 13, 2011·Journal of Biopharmaceutical Statistics·Xuefeng Li, Yunling Xu
Aug 13, 2011·Journal of Biopharmaceutical Statistics·Gregory Campbell
Aug 13, 2011·Journal of Biopharmaceutical Statistics·John A ScottLayla S Sian
Aug 15, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Michelle MoBarbara E Ehrlich
Jul 3, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David Kudlowitz, Franco Muggia
Dec 5, 2013·Pharmaceutics·Bin YaoH Amy Xia
Apr 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dawn L HershmanCharles L Loprinzi
Citations
Dec 18, 2018·Drug and Chemical Toxicology·Bingjie QinWeihong Zheng
Sep 9, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jennifer S GewandterKaren M Mustian
Jun 17, 2020·Basic & Clinical Pharmacology & Toxicology·Fatemeh AmirkhanlooAhmad Reza Dehpour
Aug 29, 2020·Integrative Cancer Therapies·Ester OnedaAlberto Zaniboni
Aug 28, 2020·Molecular Cancer Therapeutics·Xiao-Min WangChi Wai Cheung
Nov 5, 2019·Journal of Tissue Engineering and Regenerative Medicine·Khaled F Al-MassriHanan S El-Abhar
Nov 15, 2019·Neuroscience Letters·Bingjie QinWeihong Zheng
Nov 30, 2019·Critical Reviews in Oncology/hematology·Eiman Y Ibrahim, Barbara E Ehrlich
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kinga SałatRobert Sałat
Jul 1, 2021·World Journal of Clinical Oncology·Ester OnedaAlberto Zaniboni
Apr 15, 2021·Asia-Pacific Journal of Oncology Nursing·Neriman Yükseltürk Şimşek, Ayten Demir
Oct 3, 2018·Asia-Pacific Journal of Oncology Nursing·Neriman Yükseltürk Simsek, Ayten Demir